...
首页> 外文期刊>Infection and immunity >Expression and immunogenicity of an Echinococcus granulosus fatty acid-binding protein in live attenuated Salmonella vaccine strains.
【24h】

Expression and immunogenicity of an Echinococcus granulosus fatty acid-binding protein in live attenuated Salmonella vaccine strains.

机译:沙门氏菌减毒活疫苗株中细粒棘球fatty脂肪酸结合蛋白的表达和免疫原性。

获取原文

摘要

Fatty acid-binding proteins (FABPs) are candidate molecules for vaccines against several parasitic platyhelminths. A FABP from the cestode Echinococcus granulosus (EgDf1) was expressed in Salmonella vaccine strains as a C-terminal fusion to fragment C of tetanus toxin (TetC) by using expression vector pTECH. The fusion protein was equally expressed in several attenuated vaccine strains derived from bacteria with different genetic backgrounds and different attenuating mutations. Single-dose immunization experiments with the aroA Salmonella typhimurium strain SL3261 carrying the pTECH-EgDf1 construct were conducted with mice, using both the intravenous and the oral routes. Surprisingly, the antibody response to EgDf1 and the antigen-specific cytokine production in spleen cells were stronger in mice immunized orally. Furthermore, immune mouse sera strongly reacted with fixed sections of the worm's larval stage. Analysis of the isotype distribution of the specific anti-EgDf1 antibodies showed similar production of immunoglobulin G1 (IgG1) and IgG2a together with specific IgA antibodies. In addition, stimulation of spleen cells from mice immunized with the different constructs with either Salmonella lysate, TetC, or EgDf1 showed that, together with Th1-related cytokines (gamma interferon and interleukin 2 [IL-2]), significant levels of a Th2 cytokine (IL-5) were produced specifically, indicating a Th2 component to the response to the Salmonella carrier and to the recombinant antigens. Salmonellae expressing the TetC-rEgDfl fusion are currently under evaluation as potential vaccines against E. granulosus.
机译:脂肪酸结合蛋白(FABP)是针对几种寄生性疟原虫的疫苗的候选分子。使用表达载体pTECH,沙门氏菌细粒棘球oc虫(EgDf1)的FABP在沙门氏菌疫苗株中表达为破伤风毒素(TetC)C片段的C端融合体。融合蛋白在衍生自具有不同遗传背景和不同减毒突变的细菌的几种减毒疫苗株中均均表达。携带pTECH-EgDf1构建体的aroA鼠伤寒沙门氏菌SL3261菌株通过静脉和口服途径与小鼠进行了单剂量免疫实验。令人惊讶的是,在口服免疫的小鼠中,对EgDf1的抗体反应和脾细胞中抗原特异性细胞因子的产生更强。此外,免疫小鼠血清与蠕虫幼虫阶段的固定部分强烈反应。特异性抗EgDf1抗体同种型分布的分析显示,免疫球蛋白G1(IgG1)和IgG2a与特异性IgA抗体的产生相似。此外,用沙门氏菌溶胞产物,TetC或EgDf1刺激了用不同构建体免疫的小鼠的脾细胞,结果表明与Th1相关细胞因子(γ干扰素和白介素2 [IL-2])一起,Th2水平显着特异性产生了细胞因子(IL-5),表明Th2组分对沙门氏菌载体和重组抗原的应答。目前正在评估表达TetC-rEgDf1融合蛋白的沙门氏菌作为抗颗粒大肠杆菌的潜在疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号